The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 4, 2004, Pages 335-342

  Chuansumrit, Ampaiwan ^a,b   Tangnararatchakit, Kanchana ^a   Lektakul, Yujinda ^c   Pongthanapisith, Viroj ^b   Nimjaroenniyom, Nuntaporn ^d   Thanarattanakorn, Pattra ^e   Wongchanchailert, Malai ^f   Komwilaisak, Patcharee ^g  

^a Department of Pediatrics ^*  (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Sappasitthiprasong Hospital   (Thailand)

^d KHON KAEN HOSPITAL   (Thailand)

^e Faculty of Medicine Chiang Mai University   (Thailand)

^f PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^g KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Dengue Shock Syndrome; Recombinant activated factor VII

Indexed keywords

DEXTRAN; GELATIN; IBUPROFEN; POLYGELINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ADOLESCENT; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE COURSE; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CRITICAL ILLNESS; DENGUE HEMORRHAGIC FEVER; FACTOR VII; FEMALE; HEMORRHAGE; HUMANS; MALE; PLATELET TRANSFUSION; PROTHROMBIN TIME; RECOMBINANT PROTEINS; SURVIVAL RATE; THAILAND; TREATMENT OUTCOME;

EID: 2942615463     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200406000-00008     Document Type: Article

References (20)

1. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet 1998; 352:971-977.
2. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd edition, Chapter 2. Geneva: WHO; 1997, pp. 12-23.
3. Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:975-984.
4. Mitrakul C. Bleeding diathesis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1979; 10:434-437.
5. Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Bailliere Best Pract Res Clin Hematol 2000; 13:261-276.
6. Nimmannitya S. Dengue haemorrhagic fever: current issues and future research. Asian-Oceanian J Pediatr Child Health 2002; 1:1-20.
7. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26(suppl 1):159-164.
8. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa [Letter]. Lancet 1999; 354:1879.
9. Ramathibodi Clinical Practice Guideline. Dengue hemorrhagic fever. In: Benjaponpitak S, Wanitkun S, Tangnararatchakit K, Chantanarojanasiri T, Suwanjutha S (editors): Pediatric critical care, 2nd edition. Bangkok: Bejorn Enterprise; 2002, pp. 253-260.
10. Brozovic M, Stirling Y, Harricks C, North WR, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28:381-391.
11. Lum LC, Goh AY, Chan PW, EL-Amin AL, Lam SK. Risk factor for hemorrhage in severe dengue infections. J Pediatr 2002; 140:629-631.
12. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-1330.
13. Krishnamurit C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001; 65:840-847.
14. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Semin Hematol 2001; 38(4 suppl 12):43-47.
15. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270:14477-14484.
16. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29:1261-1267.
17. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61:500-510.
18. Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000; 31:10-14.
19. Pongpanich B, Bhanchet-Isarangkura P. Dengue haemorrhagic fever. Current concept in management. Mother Child 1980; 7:23-29.
20. Thisyakorn U, Thisyakorn C. Dengue infection with unusual manifestations. J Med Assoc Thai 1994; 77:410-413.